Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v4-FR Version v1-EN
Language French English
Date Updated 2020-01-14 2019-12-12
Drug Identification Number 02411334 02411334
Brand name APO-AMLODIPINE-ATORVASTATIN APO-AMLODIPINE-ATORVASTATIN
Common or Proper name AMLODIPINE AMLODIPINE
Company Name APOTEX INC APOTEX INC
Ingredients AMLODIPINE ATORVASTATIN AMLODIPINE ATORVASTATIN
Strength(s) 10MG 40MG 10MG 40MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL
Packaging size 100 BTL 100 BTL
ATC code C10BX C10BX
ATC description LIPID MODIFYING AGENTS, COMBINATIONS LIPID MODIFYING AGENTS, COMBINATIONS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2019-12-09 2019-12-09
Estimated end date 2020-01-19 2020-01-19
Actual end date 2020-01-14
Shortage status Actual shortage Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments